comparemela.com

Latest Breaking News On - Nasdaq cmnd - Page 2 : comparemela.com

Clearmind Medicine Stock Set to Reverse Split on Tuesday, November 28th (NASDAQ:CMND)

Clearmind Medicine Inc. (NASDAQ:CMND – Free Report)’s stock is going to reverse split on Tuesday, November 28th. The 1-30 reverse split was announced on Tuesday, November 28th. The number of shares owned by shareholders will be adjusted after the closing bell on Tuesday, November 28th. Clearmind Medicine Price Performance Shares of CMND stock opened at […]

Clearmind Medicine (NASDAQ:CMND) Stock to Reverse Split on Tuesday, November 28th

Clearmind Medicine Inc. (NASDAQ:CMND – Free Report)’s stock is going to reverse split on the morning of Tuesday, November 28th. The 1-30 reverse split was announced on Tuesday, November 28th. The number of shares owned by shareholders will be adjusted after the closing bell on Tuesday, November 28th. Clearmind Medicine Trading Up 0.8 % Shares […]

Clearmind Medicine Inc (NASDAQ:CMND) Short Interest Down 90 1% in October

Clearmind Medicine Inc. (NASDAQ:CMND – Get Free Report) was the recipient of a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 322,000 shares, a decline of 90.1% from the October 15th total of 3,240,000 shares. Based on an average daily volume of 2,000,000 shares, […]

Short Interest in Clearmind Medicine Inc (NASDAQ:CMND) Declines By 69 0%

Clearmind Medicine Inc. (NASDAQ:CMND – Get Free Report) saw a significant decrease in short interest in September. As of September 30th, there was short interest totalling 145,300 shares, a decrease of 69.0% from the September 15th total of 468,400 shares. Based on an average daily volume of 464,000 shares, the short-interest ratio is currently 0.3 […]

Clearmind Medicine Announces Pricing of US$2 25 Million

Tel Aviv, Israel / Vancouver, Canada, Sept. 14, 2023 (GLOBE NEWSWIRE) Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind”), a.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.